Pfizer Inc Analyst and Investor Call to Discuss Proposed Acquisition of Seagen Inc Call Transcript
Good day, everyone, and welcome to Pfizer's Analyst and Investor Call to discuss proposed acquisition of Seagen. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.
Thank you for joining our call today on short notice. Today's call will last approximately 60 minutes. We will start with some prepared remarks followed by a question-and-answer session. Before I begin, let me remind you that Pfizer and Seagen will be making forward-looking statements during the course of this call that are subject to substantial risks and uncertainties. We undertake no obligation to update those statements and any comments we make are valid only as of today. For additional information, please see the press release regarding the proposed transaction that we issued today and the SEC Form 10-Q and 10-K filings with the companies in the sections entitled Risk Factors and Forward-Looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
